Eczema study sheds light on skin disease and treatment options
NCT ID NCT04818138
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study aimed to better understand eczema by collecting data, blood, and skin samples from 69 participants across Canada. It also compared two types of light therapy (broadband vs narrowband UVB) to see which works better for treating eczema. The study was terminated early, so results may be limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Women's College Hospital
Toronto, Ontario, M5S 1B2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene therapy gel targets rare blistering skin disease
- Could a common antibiotic boost eczema treatment?
- New biologic drug aims to clear stubborn eczema in just 24 weeks
- Skin disease evolution under the microscope: a 17-Year look at what drives severity
- Could a simple body wash and cream soothe eczema without a prescription?
- Skin sodium levels may hold clues to eczema in older adults